CZMWY OTC
Carl Zeiss Meditec AG
1W: -1.0%
1M: -7.4%
3M: +7.3%
YTD: -24.2%
1Y: -31.5%
3Y: -58.5%
5Y: -83.9%
$35.14
+0.14 (+0.41%)
Weekly Expected Move ±3.8%
$32
$34
$35
$36
$38
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$232M
-6.3% ▼
5Y CAGR: +5.4%
Capital Expenditures
$43M
+71.4% ▲
5Y CAGR: -0.7%
Free Cash Flow
$188M
+97.9% ▲
5Y CAGR: +7.1%
Dividends Paid
$58M
+41.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$9M
-2.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $238M | $294M | $292M | $180M | $142M |
| Depreciation & Amort. | $62M | $70M | $74M | $133M | $126M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $52M | -$110M | -$126M | $15M | -$37M |
| Other Non-Cash Items | $12M | -$59M | $11M | -$81M | -$375K |
| Operating Cash Flow | $363M | $188M | $251M | $247M | $232M |
| — Investing Activities — | |||||
| Capital Expenditures | -$66M | -$82M | -$66M | -$87M | -$39M |
| Acquisitions (Net) | -$12M | -$61M | -$11M | -$1.0B | -$2M |
| Investment Purchases | -$2M | -$6M | -$22M | -$4M | -$26M |
| Investment Sales | -$36M | $56M | $35M | $750M | $0 |
| Other Investing | $40M | -$56M | -$48M | -$65M | -$33M |
| Investing Cash Flow | -$75M | -$149M | -$111M | -$412M | -$100M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$14M | -$2M | -$8K | $400M | $75K |
| Stock Repurchased | $0 | $0 | $0 | -$150M | $0 |
| Dividends Paid | -$45M | -$80M | -$98M | -$98M | -$58M |
| Other Financing | -$227M | -$12M | -$37M | $24M | -$62M |
| Financing Cash Flow | -$286M | -$94M | -$135M | $176M | -$120M |
| Net Change in Cash | $1M | $290K | $3M | $10M | $9M |
| Cash End of Period | $7M | $8M | $11M | $20M | $32M |
| Free Cash Flow | $297M | $106M | $137M | $95M | $188M |